Hepion Pharmaceuticals Quote - HEPA

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.0813

Bid

0.0792

Offer

0.27

Volume

8,470,173

0.077 Day's Range 0.0909

0.077 52 Week Range 2.8999

Market Cap

565.716k

Previous Close

0.0863

Open

0.0869

Last Trade

300

0.0813

(formt)

Last Trade Time

Financial Volume

US$ 716,830

VWAP

0.08463

Average Volume (3m)

12,909,159

Shares Outstanding

6,958,371

Dividend Yield

PE Ratio

-0.01

Earnings Per Share (EPS)

-7.03

Revenue

Net Profit

-48.93M

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.hepion.com

Headquarters

Wilmington, Delaware, USA

Founded

Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HEPA. The last closing price for Hepion Pharmaceuticals was US$0.09. Over the last year, Hepion Pharmaceuticals shares have traded in a share price range of US$ 0.077 to US$ 2.8999.

Hepion Pharmaceuticals currently has 6,958,371 shares in issue. The market capitalisation of Hepion Pharmaceuticals is US$600,507.42 . Hepion Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.01.

Hepion Pharmaceuticals Announces $9.0 Million Public Offering

EDISON, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage...

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form 8-K - Current report

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to...

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

KIRYAT ONO, ISRAEL and EDISON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0587	-41.9285714286	0.14	0.14105	0.077	6105915	0.10230468	CS
4	-0.0957	-54.0677966102	0.177	0.2252	0.077	10782101	0.17615727	CS
12	-0.5286	-86.6699458928	0.6099	0.7345	0.077	12909159	0.19643821	CS
26	-0.6187	-88.3857142857	0.7	0.89	0.077	5690780	0.1984925	CS
52	-2.3487	-96.6543209877	2.43	2.8999	0.077	2860486	0.21268825	CS
156	-24.5187	-99.6695121951	24.6	26.6	0.077	1111115	2.25072428	CS
260	-47.9187	-99.830625	48	123.6	0.077	1438737	24.38447516	CS

HEPA - Frequently Asked Questions (FAQ)

What is the current Hepion Pharmaceuticals share price?

The current share price of Hepion Pharmaceuticals is US$ 0.0813

How many Hepion Pharmaceuticals shares are in issue?

Hepion Pharmaceuticals has 6,958,371 shares in issue

What is the market cap of Hepion Pharmaceuticals?

The market capitalisation of Hepion Pharmaceuticals is USD 600.51k

What is the 1 year trading range for Hepion Pharmaceuticals share price?

Hepion Pharmaceuticals has traded in the range of US$ 0.077 to US$ 2.8999 during the past year

What is the PE ratio of Hepion Pharmaceuticals?

The price to earnings ratio of Hepion Pharmaceuticals is -0.01

What is the reporting currency for Hepion Pharmaceuticals?

Hepion Pharmaceuticals reports financial results in USD

What is the latest annual profit for Hepion Pharmaceuticals?

The latest annual profit of Hepion Pharmaceuticals is USD -48.93M

What is the registered address of Hepion Pharmaceuticals?

The registered address for Hepion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Hepion Pharmaceuticals website address?

The website address for Hepion Pharmaceuticals is www.hepion.com

Which industry sector does Hepion Pharmaceuticals operate in?

Hepion Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Symbol	Price	Vol.
CAPSCapstone Holding Corp	US$ 3.50 (1,300.00%)	36.33k
ABLVAble View Global Inc	US$ 1.73 (137.18%)	5.13M
SUNESUNation Energy Inc	US$ 0.402999 (127.55%)	476.73M
BTOGBit Origin Ltd	US$ 0.6117 (118.46%)	618.03M
DWTXDogwood Therapeutics Inc	US$ 6.63 (49.66%)	25.77M
ALBTAvalon GloboCare Corporation	US$ 6.96 (-36.15%)	577.55k
SCNXScienture Holdings Inc	US$ 1.55 (-35.68%)	1.59M
ACXPAcurx Pharmaceuticals Inc	US$ 0.4572 (-29.88%)	1.18M
RETOReTo Eco Solutions Inc	US$ 5.42 (-27.73%)	108.27k
OCTOEightco Holdings Inc	US$ 1.08 (-27.03%)	336.99k
BTOGBit Origin Ltd	US$ 0.6117 (118.46%)	622.67M
SUNESUNation Energy Inc	US$ 0.402999 (127.55%)	482.05M
NVDANVIDIA Corporation	US$ 112.69 (1.92%)	341.94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 10.675 (-0.70%)	143.04M
ICONIcon Energy Corporation	US$ 0.169898 (17.17%)	142.23M

Symbol

Price

Vol.